BR-1018
- Generic Name
- BR-1018
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of BR1018 and Coadministration of BR1018A and BR1018B in Healthy Adult Volunteers
Phase 1
Not yet recruiting
- Conditions
- Essential HypertensionPrimary Hypercholesterolemia
- Interventions
- First Posted Date
- 2025-03-21
- Last Posted Date
- 2025-03-21
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 60
- Registration Number
- NCT06889012
- Locations
- 🇰🇷
Clinical Research Center, H PLUS Yangji Hospital, Seoul, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath